Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The role of hypoxia-inducible factors in tumorigenesis Rankin EB; Giaccia AJCell Death Differ 2008[Apr]; 15 (4): 678-85Hypoxia-inducible factors (HIFs) are essential mediators of the cellular oxygen-signaling pathway. They are heterodimeric transcription factors consisting of an oxygen-sensitive alpha subunit (HIF-alpha) and a constitutive beta subunit (HIF-beta) that facilitate both oxygen delivery and adaptation to oxygen deprivation by regulating the expression of genes that control glucose uptake, metabolism, angiogenesis, erythropoiesis, cell proliferation, and apoptosis. In most experimental models, the HIF pathway is a positive regulator of tumor growth as its inhibition often results in tumor suppression. In clinical samples, HIF is found elevated and correlates with poor patient prognosis in a variety of cancers. In summary, HIF regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy, making it a critical regulator of the malignant phenotype.|*Signal Transduction[MESH]|Adaptation, Physiological[MESH]|Animals[MESH]|Basic Helix-Loop-Helix Transcription Factors/*metabolism[MESH]|Cell Differentiation[MESH]|Cell Hypoxia[MESH]|Cell Proliferation[MESH]|Energy Metabolism[MESH]|Humans[MESH]|Hypoxia-Inducible Factor 1, alpha Subunit/metabolism[MESH]|Hypoxia/genetics/*metabolism/pathology[MESH]|Neoplasm Invasiveness[MESH]|Neoplasm Metastasis[MESH]|Neoplasms/genetics/*metabolism/pathology/radiotherapy[MESH]|Neovascularization, Pathologic/metabolism[MESH]|Oxygen/metabolism[MESH] |